NCT00116857View on ClinicalTrials.gov

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

November 30, 2009

Conditions
Cardiovascular DiseasesDepressionHeart DiseasesMyocardial InfarctionAngina, Unstable
Interventions
DRUG

Sertraline/omega-3

Sertraline (50 mgs) plus omega-3 (2 grams)

DRUG

Sertraline/Corn Oil

Sertraline (50 mgs) plus corn oil (2 grams) (placebo)

Trial Locations (1)

63108

Washington University, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER

NCT00116857 - Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors | Biotech Hunter | Biotech Hunter